Imaging in Post-COVID Lung Disease: Does <sup>18</sup>F-FDG PET/CT Have the Key?

Gheysens, Olivier; Belkhir, Leïla; Jamar, François

Imaging in Post-COVID Lung Disease: Does ¹⁸F-FDG PET/CT Have the Key?

Gheysens, Olivier; Belkhir, Leïla; Jamar, François.

Gheysens O; Department of Nuclear Medicine, Cliniques Universitaires St-Luc and Institute for Clinical and Experimental Research, Université Catholique de Louvain, Brussels, Belgium; and.
Belkhir L; Department of Internal Medicine and Infectiology, Cliniques Universitaires St-Luc and Institute for Clinical and Experimental Research, Université Catholique de Louvain, Brussels, Belgium.
Jamar F; Department of Nuclear Medicine, Cliniques Universitaires St-Luc and Institute for Clinical and Experimental Research, Université Catholique de Louvain, Brussels, Belgium; and francois.jamar@uclouvain.be.

J Nucl Med ; 63(2): 268-269, 2022 02.

Article in English | MEDLINE | ID: covidwho-2260531

Subject(s)

COVID-19; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography/methods; Positron-Emission Tomography; Radiopharmaceuticals

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fluorodeoxyglucose F18 / COVID-19 Topics: Long Covid Limits: Humans Language: English Journal: J Nucl Med Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google